Zack Bloom Associate Corporate Zack advises life sciences and technology companies on a broad range of corporate and transactional matters. Before joining Fenwick, Zack was an associate at a prominent international law firm in Boston.
Media Coverage Fenwick’s Dave Bell Discusses California Board Diversity Law with The New York Times April 7, 2022
Publications SEC Proposes New Rules to Enhance Disclosure and Investor Protection Relating to SPACs and Projections – Impact on Target Companies April 6, 2022
Experience Fenwick Represents Melinta Therapeutics in Acquisition of U.S. Rights to TOPROL-XL from New American Therapeutics April 6, 2022
